Richard S. Lemons

2.0k total citations
39 papers, 962 citations indexed

About

Richard S. Lemons is a scholar working on Molecular Biology, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Richard S. Lemons has authored 39 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Richard S. Lemons's work include Retinoids in leukemia and cellular processes (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Neuroblastoma Research and Treatments (4 papers). Richard S. Lemons is often cited by papers focused on Retinoids in leukemia and cellular processes (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Neuroblastoma Research and Treatments (4 papers). Richard S. Lemons collaborates with scholars based in United States, Italy and Germany. Richard S. Lemons's co-authors include C. Patrick Reynolds, Michelle M. Le Beau, Gerd M. Rosenblatt, Charles J. Sherr, Stephen J. O’Brien, Robert D. Christensen, Hassan M. Yaish, M. Watson, Thad A. Howard and Stephen F. Kingsmore and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Richard S. Lemons

38 papers receiving 902 citations

Peers

Richard S. Lemons
Charles H. Packman United States
T A Waldmann United States
Mehdi Nassiri United States
Ho Sup Lee South Korea
Amiel G. Cooper United States
Jill Moss United Kingdom
Richard Moscicki United States
Robert J. Marder United States
Charles H. Packman United States
Richard S. Lemons
Citations per year, relative to Richard S. Lemons Richard S. Lemons (= 1×) peers Charles H. Packman

Countries citing papers authored by Richard S. Lemons

Since Specialization
Citations

This map shows the geographic impact of Richard S. Lemons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard S. Lemons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard S. Lemons more than expected).

Fields of papers citing papers by Richard S. Lemons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard S. Lemons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard S. Lemons. The network helps show where Richard S. Lemons may publish in the future.

Co-authorship network of co-authors of Richard S. Lemons

This figure shows the co-authorship network connecting the top 25 collaborators of Richard S. Lemons. A scholar is included among the top collaborators of Richard S. Lemons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard S. Lemons. Richard S. Lemons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Connell, Niamh, Paul van der Valk, Sandra Le Quellec, et al.. (2024). Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B. Journal of Thrombosis and Haemostasis. 23(1). 73–84. 1 indexed citations
2.
Constance, Jonathan E., Mary McFarland, Michael W. Deininger, et al.. (2023). Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review. JMIR Research Protocols. 12. e38167–e38167. 1 indexed citations
3.
Lemons, Richard S., et al.. (2023). Safety and efficacy of recombinant Factor IX fusion protein (rIX-FP) in previously untreated patients with haemophilia B. Hämostaseologie. 43(S 01). S41–S42. 1 indexed citations
4.
Rower, Joseph E., Diana G. Wilkins, Jacob Wilkes, et al.. (2020). Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer. Journal of Adolescent and Young Adult Oncology. 10(2). 175–184. 5 indexed citations
5.
Polishchuk, Alexei L., Richard Li, Christine E. Hill‐Kayser, et al.. (2014). Likelihood of Bone Recurrence in Prior Sites of Metastasis in Patients With High-Risk Neuroblastoma. International Journal of Radiation Oncology*Biology*Physics. 89(4). 839–845. 26 indexed citations
6.
Lemons, Richard S., et al.. (2003). Safety, Dose, and Timing of Reteplase in Treating Occluded Central Venous Catheters in Children With Cancer. Journal of Pediatric Hematology/Oncology. 25(11). 864–867. 18 indexed citations
7.
Hong, Bo, Zhong Chen, Cheryl M. Coffin, et al.. (2003). Molecular cytogenetic analysis of a pleuropulmonary blastoma. Cancer Genetics and Cytogenetics. 142(1). 65–69. 10 indexed citations
8.
Reynolds, C. Patrick & Richard S. Lemons. (2001). RETINOID THERAPY OF CHILDHOOD CANCER. Hematology/Oncology Clinics of North America. 15(5). 867–910. 103 indexed citations
9.
Brothman, Arthur R., et al.. (1994). Multiple congenital anomalies in a man with (X;6) translocation. American Journal of Medical Genetics. 51(1). 9–12. 16 indexed citations
10.
Espinosa, R, et al.. (1991). Localization of the gene encoding insulin-degrading enzyme to human chromosome 10, bands q23→q25. Cytogenetic and Genome Research. 57(4). 184–186. 11 indexed citations
11.
Morgan, R, et al.. (1991). t(16;21)(p11.2;q22): A recurrent primary rearrangement in ANLL. Cancer Genetics and Cytogenetics. 53(1). 83–90. 17 indexed citations
12.
Lemons, Richard S., et al.. (1990). Cloning and characterization of the T(15;17) translocation breakpoint region in acute promyelocytic leukemia. Genes Chromosomes and Cancer. 2(2). 79–87. 55 indexed citations
13.
Watson, M., Stephen F. Kingsmore, Geoffrey I. Johnston, et al.. (1990). Genomic organization of the selectin family of leukocyte adhesion molecules on human and mouse chromosome 1.. The Journal of Experimental Medicine. 172(1). 263–272. 112 indexed citations
14.
Beau, Michelle M. Le, et al.. (1990). Chromosomal localization of the human hexabrachion (tenascin) gene and evidence for recent reduplication within the gene. Genomics. 6(4). 616–622. 31 indexed citations
15.
Lemons, Richard S., et al.. (1990). Chromosomal localization of the gene encoding GTPase-activating protein (RASA) to human chromosome 5, bands q13–q15. Genomics. 6(2). 383–385. 4 indexed citations
16.
Adams, Roberta H., Richard S. Lemons, Maya Thangavelu, Michelle M. Le Beau, & Robert D. Christensen. (1989). Interstitial deletion of chromosome 5, del(5q), in a newborn with down syndrome and an unusual hematologic disorder. American Journal of Hematology. 31(4). 273–279. 10 indexed citations
17.
Wetsel, Rick A., Richard S. Lemons, Michelle M. Le Beau, et al.. (1988). Molecular analysis of human complement component C5: localization of the structural gene to chromosome 9. Biochemistry. 27(5). 1474–1482. 46 indexed citations
18.
Lublin, Douglas M., Richard S. Lemons, Michelle M. Le Beau, et al.. (1987). The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1.. The Journal of Experimental Medicine. 165(6). 1731–1736. 71 indexed citations
19.
Lemons, Richard S., William G. Nash, Stephen J. O’Brien, Raoul Ė. Benveniste, & Charles J. Sherr. (1978). A gene (Bevi) on human chromosome 6 is an integration site for baboon type C DNA provirus in human cells. Cell. 14(4). 995–1005. 41 indexed citations
20.
Lemons, Richard S. & Gerd M. Rosenblatt. (1976). Thermal accommodation coefficients by high speed vibration of solid samples. Surface Science. 59(1). 293–296. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026